Ironwood Pharmaceuticals (IRWD) Total Current Liabilities (2016 - 2025)
Ironwood Pharmaceuticals (IRWD) has disclosed Total Current Liabilities for 16 consecutive years, with $242.2 million as the latest value for Q4 2025.
- Quarterly Total Current Liabilities rose 523.53% to $242.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $242.2 million through Dec 2025, up 523.53% year-over-year, with the annual reading at $242.2 million for FY2025, 523.53% up from the prior year.
- Total Current Liabilities hit $242.2 million in Q4 2025 for Ironwood Pharmaceuticals, roughly flat from $242.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $305.4 million in Q2 2023 to a low of $23.3 million in Q2 2022.
- Historically, Total Current Liabilities has averaged $136.3 million across 5 years, with a median of $140.0 million in 2021.
- Biggest five-year swings in Total Current Liabilities: skyrocketed 1210.8% in 2023 and later tumbled 85.93% in 2024.
- Year by year, Total Current Liabilities stood at $161.7 million in 2021, then tumbled by 84.21% to $25.5 million in 2022, then skyrocketed by 981.69% to $276.1 million in 2023, then crashed by 85.93% to $38.8 million in 2024, then surged by 523.53% to $242.2 million in 2025.
- Business Quant data shows Total Current Liabilities for IRWD at $242.2 million in Q4 2025, $242.5 million in Q3 2025, and $232.5 million in Q2 2025.